Senate Bill Would Create New Category for Drugs Substantively Similar to Controlled Substances
Sens. Chuck Grassley, R-Iowa, and Dianne Feinstein, D-Calif., introduced legislation that would add substances to a new category of controlled substances called “Schedule A” if their chemical structure is substantially similar to an existing controlled substance and they are expected…
Sign up for a free preview to unlock the rest of this article
Timely, relevant coverage of court proceedings and agency rulings involving tariffs, classification, valuation, origin and antidumping and countervailing duties. Each day, Trade Law Daily subscribers receive a daily headline email, in-depth PDF edition and access to all relevant documents via our trade law source document library and website.
to have the same as or a greater effect on the human body than the current substance, Grassley’s office announced (here). The Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 would apply existing Schedule III criminal penalties for manufacturers and traffickers of “Schedule A” substances, but would not impose new mandatory minimum sentences and not criminalize “simple possession of a Schedule A substance,” the announcement says. The legislation would allow legitimate research on “Schedule A” substances to continue.